cardiogenic and distributive shock Circulatory shock
Conditions
Interventions
Included patients will undergo treatment after cardiothoracic surgery according
to current clinical practice. Microcirculation measurement with the CytoCam
will be performed as soon as possible afte
Sponsors
Academisch Medisch Centrum
Eligibility
Age
18 Years to 99 Years
Inclusion criteria
Inclusion criteria: - Age of patient is at least 18 years - Patients are admitted to the ICU after cardiothoracic surgery
Exclusion criteria
Exclusion criteria: - Patients who refuse to take part in the study - Patients younger than 18 years - Patients with maxillofacial trauma - Patients known with tumor(s) in the mouth or throat area
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Primary study outcome The primary outcome is the time course of microcirculatory parameters in patients admitted to the ICU after cardiothoracic surgery with and without circulatory shock. | — |
Secondary
| Measure | Time frame |
|---|---|
| Secondary study outcomes include: • The time course of microcirculatory parameters in patients admitted to the ICU after cardiothoracic surgery with and without circulatory shock • The coherence between the maicrocirculation and microcirculation in patients admitted to the ICU after cardiothoracic surgery with and without circulatory shock. Coherence meaning whether changes in microcirculatory parameters are congruent with (in the same direction of) expected changes in the microcirculation. • The relationship between the microcirculation and vital organ (dys)function, particularly the need for vasopressors and/or inotropic therapy or duration of mechanical support. • The association between microcirculation and clinical outcomes (i.e. acute kidney injury, the need for continuous venovenous hemofiltration, Iength of stay ICU and ICU mortality | — |
Countries
Netherlands
Outcome results
None listed